Previous 10 | Next 10 |
WESTPORT, CT / ACCESSWIRE / February 22, 2023 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct" or the "Company"), is a company focused on developing life-enhancing breast healthcare products, recently attended the 11th International Symposium on the Human Breast hosted by Dr. Susan Love Foun...
WESTPORT, CT / ACCESSWIRE / January 19, 2023 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct" or the "Company"), is a company focused on developing life-enhancing breast healthcare products, and today provides an update on its corporate guidance outlook for 2023. The Company's corporate stra...
WESTPORT, CT / ACCESSWIRE / October 4, 2022 / CYduct Diagnostics, Inc. (OTC PINK:CYDX), a medical device company pursuing innovations within the women's healthcare market, primarily breast healthcare and wellness, is pleased to announce that TPS Thayer LLC, an independent audit firm, has com...
WESTPORT, CT / ACCESSWIRE / August 18, 2022 / CYduct Diagnostics, Inc. (OTC PINKK:CYDX), a medical device company pursuing innovations within the women's healthcare market, primarily breast healthcare and wellness, today provides a corporate update and letter from President, Dominick Gatto. ...
WESTPORT, CT / ACCESSWIRE / May 9, 2022 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct") is pleased to announce it has joined BioCT, Connecticut's Biosciences Community. Commenting on CYduct's membership into BioCT, Dominick Gatto, CYduct's Chief Executive Officer stated, "We look forw...
WESTPORT, CT / ACCESSWIRE / November 15, 2021 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct") is pleased to announce the retaining of Ms. Laura Anthony and the firm Anthony L.G., PLLC. Commenting on the appointment of Anthony L.G., PLLC, Dominick Gatto, CYduct's Chief Executive Office...
WESTPORT, CT / ACCESSWIRE / September 30, 2021 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct") yesterday filed with OTC Markets its financial results for the fiscal years-ended June 30, 2021 and 2020. Commenting on the Company's fiscal 2021 financial performance and key corporate miles...
WESTPORT, CT / ACCESSWIRE / June 24, 2021 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct") is pleased to announce today that the company has retained the public accounting firm TPS Thayer, LLC. TPS Thayer has been retained to perform audit services for the years ended June 30, 2020, and...
WESTPORT, CT / ACCESSWIRE / May 12, 2021 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) is pleased to announce it has signed and closed an agreement to acquire all the assets of HHC PREFERRED LLC. CYduct Diagnostics, an emerging innovator in the breast healthcare wellness segment of women's hea...
CYduct Diagnostics ([[CYDX]]) has entered into a Sponsored research agreement with Yale University to test and evaluate the performance of the University's nanowire biosensor technology for detecting critical protein biomarkers associated with the progression of breast cancer.The agreeme...
News, Short Squeeze, Breakout and More Instantly...
Cyduct Diagnostics Inc Company Name:
CYDX Stock Symbol:
OTCMKTS Market:
Westport, Connecticut--(Newsfile Corp. - May 22, 2024) - CYduct Diagnostics (OTC Pink: CYDX), CYductDX is a disruptive clinical-stage diagnostic company led by an experienced team of senior executives and scientists focused on proprietary technologies for the early assessment and detection of B...
Yale Innovation Summit, May 29-30, New Haven, CT. WESTPORT, CT / ACCESSWIRE / May 16, 2024 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct", "CYductDX", or the "Company"), an innovator in precision breast health enabled by non-invasive intraductal platforms, today announced it is please...
WESTPORT, CT / ACCESSWIRE / April 2, 2024 / CYduct Diagnostics, Inc. (OTC PINK:CYDX) ("CYduct", or the "Company"), a precision medicine-based women's health company focused on the development of breast cancer risk assessment and diagnostic tools, today announced positive results from its recent ...